The global blood culture test market was valued at around US$ 4.4 Billion at the end of 2021. The market is projected to register a 4.9% CAGR and top a valuation of US$ 7.2 Billion by 2032.
High incidence of bloodstream infections, increasing adoption rate, and growing awareness among patients are expected to uplift the blood culture test market growth.
The microbiological culture of blood is known as blood culture, and it is used to identify infections that are spreading via the bloodstream. Early detection of blood infections is essential to avoid further consequences because the majority of blood infections are brought by bacteria entering the bloodstream through the lungs, skin, urine, or gastrointestinal system. Among the infections that spread through the bloodstream are septicemia and bacteremia. The results of the culture test can help to identify the particular microorganisms causing the infection and suggest treatment options.
| Attributes | Details |
|---|---|
| Blood Culture Test Market Value in 2021 | US$ 4.4 Billion |
| Blood Culture Test Market Value in 2032 | US$ 7.2 Billion |
| Blood Culture Test Market CAGR (2022 to 2032) | 4.9% |
A major factor driving the demand for blood culture tests is the increasing incidence of sepsis and other blood-related clinical conditions. Expanding opportunities for the blood culture tests market will be brought by the higher approval rate of new products such as consumables and instruments for diagnosing Bloodstream Infections (BSI). Furthermore, Bloodstream Infections is a global concern and many people affected with this disorder will further need blood culture tests for identification will increase market expansion in the forecasted period.
The growing aging population and advancement in medical technologies, government awareness resulting in the rising government initiatives, and awareness among people in developed as well as developing countries all are factors that will boost the market expansion of the blood culture tests market.
The established economy of North America is anticipated to drive demand for blood culture tests, followed by Europe and the Asian region. In North America technically advanced healthcare infrastructure, high patient awareness, and significant healthcare spending all are contributing factors to market expansion in this region. Furthermore, advanced Medtech techniques like electro-spray ionization and Bac Spectrum assay increase the growth of the market.
Furthermore, rising disease incidences, favorable government initiatives, and investment in research and development regions are expected to experience rapid growth in the blood culture test market in the European regions. Moreover, Latin America and the East and South Asia regions are likely to experience sustainable growth in the forecast period due to the increasing population.
Some of the market players operating in the blood culture tests market are bioMérieux SA, Roche Diagnostics, Becton Dickinson, Siemens AG, Thermo Fisher Scientific Inc., Bruker Corporation, Cepheid, Alere Inc., Nanosphere, Danaher Corporation, and Abbott Laboratories.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 4.9% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Product, Technology, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Players | bioMérieux SA; Roche Diagnostics; Becton Dickinson; Siemens AG; Thermo Fisher Scientific Inc.; Bruker Corporation; Cepheid, Alere Inc.; Nanosphere; Danaher Corporation; Abbott Laboratories |
| Customization | Available Upon Request |
The global blood culture test market is anticipated to register a CAGR of 4.9% during the forecast period.
The top players in the global blood culture test market are bioMérieux SA, Roche Diagnostics, Becton Dickinson, Siemens AG, Thermo Fisher Scientific Inc., Bruker Corporation, Cepheid, Alere Inc., Nanosphere, Danaher Corporation, and Abbott Laboratories.
Explore Similar Insights
Blood Culture Test Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
